{"id":234,"date":"2019-11-12T17:43:11","date_gmt":"2019-11-12T22:43:11","guid":{"rendered":"https:\/\/opentextbc.ca\/nursingpharmacology\/chapter\/5-7-decongestants\/"},"modified":"2023-08-15T12:58:57","modified_gmt":"2023-08-15T16:58:57","slug":"5-7-decongestants","status":"publish","type":"chapter","link":"https:\/\/opentextbc.ca\/nursingpharmacology\/chapter\/5-7-decongestants\/","title":{"raw":"5.7 Decongestants","rendered":"5.7 Decongestants"},"content":{"raw":"<h1>Decongestants<\/h1>\r\nDecongestant medications have been available over the counter (drugs that you can buy at a pharmacy without a prescription) for years.\u00a0 Although they are readily available, considerations are necessary when taking any drug. In this chapter we will explore these drugs further.\r\n\r\n<img class=\"alignright wp-image-232\" title=\"box of Sudafed\" src=\"https:\/\/opentextbc.ca\/accessibilitytoolkit\/wp-content\/uploads\/sites\/397\/2019\/11\/7184518521_84f5c6a237_w.jpg\" alt=\"A box of Sudafed.\" width=\"275\" height=\"183\" data-popupalt-original-title=\"null\" \/>\r\n<h1>Pseudoephedrine<\/h1>\r\nPseudoephedrine is an over<span style=\"text-align: initial; font-size: 14pt;\">-the-counter (OTC) decongestant (see Figure 5.7<\/span>[footnote]\"<a href=\"https:\/\/www.flickr.com\/photos\/comedynose\/7184518521\" rel=\"noopener noreferrer\">Project 366 #165: 130612 Helping Hand?<\/a>\" by <a href=\"https:\/\/www.flickr.com\/photos\/comedynose\/\" rel=\"noopener noreferrer\">Pete<\/a> is licensed under <a href=\"https:\/\/creativecommons.org\/publicdomain\/mark\/1.0\/\" rel=\"noopener noreferrer\">public domain<\/a>[\/footnote]). More details regarding pseudoephedrine are described in the <a href=\"https:\/\/opentextbc.ca\/nursingpharmacology\/chapter\/4-1-autonomic-nervous-system-introduction\/\">\"Autonomic Nervous System\" chapter<\/a>.\r\n<h2>Mechanism of Action<\/h2>\r\nPseudoephedrine acts directly on the adrenergic receptors and acts indirectly by releasing norepinephrine from its storage sites. The drug produces vasoconstriction, which shrinks nasal mucosa membranes.\r\n<h2>Indications for Use<\/h2>\r\nDecongestants relieve nasal obstruction due to inflammation.\r\n<h2>Nursing Considerations Across the Lifespan<\/h2>\r\nThis medication is not safe for children under the age of 4 years.\r\n<h2>Adverse\/Side Effects<\/h2>\r\nCommon adverse\/side effects include hypertension, dysrhythmia, dizziness, headache, insomnia, and restlessness. Some clients may experience blurred vision, tinnitus, chest tightness, dry nose, and nasal congestion.\r\n\r\nDecongestants are contraindicated in clients with severe hypertension, coronary artery disease (CAD), narrow-angle glaucoma, and some antidepressant use. Also, clients who have cardiac dysrhythmias, hyperthyroidism, DM (diabetes mellitus), prostatic hypertrophy, and glaucoma should use with caution.[footnote]Frandsen, G. &amp; Pennington, S. (2018). <em>Abrams\u2019 clinical drug: Rationales for nursing practice <\/em>(11th ed.). Wolters Kluwer.[\/footnote]\r\n<h2>Client Teaching &amp; Education<\/h2>\r\nClient must take care to follow dosing recommendations.\u00a0 If dosing standards are surpassed, some clients may experience side effects such as increased nervousness, breathing difficulties, heart rate changes, and hallucinations.[footnote]uCentral from Unbound Medicine. <a href=\"https:\/\/www.unboundmedicine.com\/ucentral\" rel=\"noopener noreferrer\">https:\/\/www.unboundmedicine.com\/ucentral<\/a>[\/footnote]\r\n<h1>Pseudoephedrine Medication Card<\/h1>\r\nNow let's take a closer look at the medication drug card on Pseudoephedrine. Medication cards are intended to assist students to learn key points about each medication class.\u00a0 Basic information related to a common generic medication in this class is outlined, including administration considerations, therapeutic effects, and side effects\/adverse effects.\u00a0 Prototype\/generic medication listed in the medication card is also hyperlinked to a free resource from <a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/index.cfm\" rel=\"noopener noreferrer\">Daily Med<\/a>.\u00a0 Because information about medication is constantly changing, nurses should always consult evidence-based resources to review current recommendations before administering specific medication.in Table 5.7.<span style=\"text-align: initial; font-size: 1em;\">[footnote]This work is a derivative of\u00a0<a href=\"https:\/\/www.oercommons.org\/authoring\/54330-pharmacology-notes-nursing-implications-for-clinic\/view\" rel=\"noopener noreferrer\">Pharmacology Notes: Nursing Implications for Clinical Practice<\/a>\u00a0by\u00a0<a href=\"https:\/\/www.oercommons.org\/profile\/213497\" rel=\"noopener noreferrer\">Gloria Velarde<\/a>\u00a0is licensed under\u00a0<a class=\"internal\" href=\"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/\" rel=\"noopener noreferrer\">CC BY-NC-SA 4.0<\/a>.[\/footnote], [footnote]Frandsen, G. &amp; Pennington, S. (2018).\u00a0<em>Abrams\u2019 clinical drug: Rationales for nursing practice\u00a0<\/em>(11th ed.). Wolters Kluwer.[\/footnote], [footnote]This work is a derivative of\u00a0<a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/\" rel=\"noopener noreferrer\">Daily Med<\/a>\u00a0by\u00a0<a href=\"https:\/\/www.nlm.nih.gov\/\" rel=\"noopener noreferrer\">U.S. National Library of Medicine<\/a><span style=\"font-size: 1em;\">\u00a0in the <a class=\"internal\" href=\"https:\/\/creativecommons.org\/share-your-work\/public-domain\/\" rel=\"noopener noreferrer\">public domain<\/a>. [\/footnote].\r\n<\/span><\/span>\r\n<div class=\"textbox textbox--learning-objectives\"><header class=\"textbox__header\">\r\n<h2 class=\"textbox__title\">Medication Card 5.7.1: Pseudoephedrine<\/h2>\r\n<\/header>\r\n<div class=\"textbox__content\">\r\n\r\n<strong>Class:<\/strong> Decongestants\r\n\r\n<strong>Prototypes:<\/strong> Pseudoephedrine (Sudafed)\r\n\r\n<strong>Mechanism: <\/strong>Sudafed is an over the counter decongestant. It acts on the adrenergic receptors by releasing norepinephrine from its storage sites.\u00a0 This causes vasoconstriction-shrinking nasal mucosa membranes.\r\n<h3>Therapeutic Effects<\/h3>\r\n<ul>\r\n \t<li>Relieves nasal congestion<\/li>\r\n \t<li>Relieves sinus congestion<\/li>\r\n \t<li>Decreases sinus pressure and decrease pain<\/li>\r\n<\/ul>\r\n<h3>Administration<\/h3>\r\n<ul>\r\n \t<li>Do not crush, chew, or break an extended release tablet<\/li>\r\n \t<li>Oral suspension is available, ensure proper measuring and dose<\/li>\r\n \t<li>Adult Doses: Immediate release: 30 to 60 mg orally every 4 to 6 hours as needed.\r\nSustained release: 120 mg orally every 12 hours as needed.\r\nSustained release suspension: 45 to 100 mg orally every 12 hours as needed.\r\nMaximum daily dose is 240 mg\/day.<\/li>\r\n<\/ul>\r\n<h3>Indications<\/h3>\r\n<ul>\r\n \t<li>Use of nasal congestion due to common cold and hay fever<\/li>\r\n \t<li>Upper respiratory allergies<\/li>\r\n \t<li>Temporarily relieves sinus congestions and pressure<\/li>\r\n<\/ul>\r\n<h3>Contraindications<\/h3>\r\n<ul>\r\n \t<li>Avoid using prolonged- greater than 7 days<\/li>\r\n \t<li>Only use this medication if advised by prescribing practitioner or pharmacist if the person has heart disease since is acts as a sympathomimetic<\/li>\r\n \t<li>This drug is banned for professional sports by the World Anti-Doping Agency as it is a stimulant and is claimed to enhance performance<\/li>\r\n \t<li>DO not use in children under 4 years of age<\/li>\r\n \t<li>DO not take if taking MAO inhibitors within 14 days, this leads to serious side effects.<\/li>\r\n \t<li>DO not take if\u00a0 taking caffeine pills, diet pills or other stimulants such as ADHA medications<\/li>\r\n<\/ul>\r\n<h3>Side Effects<\/h3>\r\n<ul>\r\n \t<li>Rebound congestion with nasal route<\/li>\r\n \t<li>Cardiovascular stimulation-fast heartbeat or pounding heart beat sensation<\/li>\r\n \t<li>Dizziness or anxiety<\/li>\r\n \t<li>Dangerously high blood pressure<\/li>\r\n \t<li>Loss of appetite<\/li>\r\n \t<li>Fever, headache, cough, or skin rash-contact doctor<\/li>\r\n<\/ul>\r\n<strong>SAFETY:<\/strong> \u00a0Cautious when administering to cardiac patients due to the stimulation it can cause\r\n<ul>\r\n \t<li>Death can occur in misuse of cough and cold drugs in very young children<\/li>\r\n \t<li>Many over the counter drugs have combination of cough and cold drugs mixed together read the label to ensure you are not taking more drugs than indicated<\/li>\r\n \t<li>Can cross into breast milk and could harm a nursing baby<\/li>\r\n<\/ul>\r\n<h3>Nursing Considerations<\/h3>\r\n<ul>\r\n \t<li>Drink at least 2-3 litres of water per day<\/li>\r\n \t<li>Ensure prescribing doctor thinks its ok to take this medication if the person has heart disease, diabetes or a thyroid disorder<\/li>\r\n<\/ul>\r\n<\/div>\r\n<\/div>","rendered":"<h1>Decongestants<\/h1>\n<p>Decongestant medications have been available over the counter (drugs that you can buy at a pharmacy without a prescription) for years.\u00a0 Although they are readily available, considerations are necessary when taking any drug. In this chapter we will explore these drugs further.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignright wp-image-232\" title=\"box of Sudafed\" src=\"https:\/\/opentextbc.ca\/accessibilitytoolkit\/wp-content\/uploads\/sites\/397\/2019\/11\/7184518521_84f5c6a237_w.jpg\" alt=\"A box of Sudafed.\" width=\"275\" height=\"183\" data-popupalt-original-title=\"null\" srcset=\"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/397\/2019\/11\/7184518521_84f5c6a237_w.jpg 399w, https:\/\/opentextbc.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/397\/2019\/11\/7184518521_84f5c6a237_w-300x200.jpg 300w, https:\/\/opentextbc.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/397\/2019\/11\/7184518521_84f5c6a237_w-65x43.jpg 65w, https:\/\/opentextbc.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/397\/2019\/11\/7184518521_84f5c6a237_w-225x150.jpg 225w, https:\/\/opentextbc.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/397\/2019\/11\/7184518521_84f5c6a237_w-350x233.jpg 350w\" sizes=\"auto, (max-width: 275px) 100vw, 275px\" \/><\/p>\n<h1>Pseudoephedrine<\/h1>\n<p>Pseudoephedrine is an over<span style=\"text-align: initial; font-size: 14pt;\">-the-counter (OTC) decongestant (see Figure 5.7<\/span><a class=\"footnote\" title=\"&quot;Project 366 #165: 130612 Helping Hand?&quot; by Pete is licensed under public domain\" id=\"return-footnote-234-1\" href=\"#footnote-234-1\" aria-label=\"Footnote 1\"><sup class=\"footnote\">[1]<\/sup><\/a>). More details regarding pseudoephedrine are described in the <a href=\"https:\/\/opentextbc.ca\/nursingpharmacology\/chapter\/4-1-autonomic-nervous-system-introduction\/\">&#8220;Autonomic Nervous System&#8221; chapter<\/a>.<\/p>\n<h2>Mechanism of Action<\/h2>\n<p>Pseudoephedrine acts directly on the adrenergic receptors and acts indirectly by releasing norepinephrine from its storage sites. The drug produces vasoconstriction, which shrinks nasal mucosa membranes.<\/p>\n<h2>Indications for Use<\/h2>\n<p>Decongestants relieve nasal obstruction due to inflammation.<\/p>\n<h2>Nursing Considerations Across the Lifespan<\/h2>\n<p>This medication is not safe for children under the age of 4 years.<\/p>\n<h2>Adverse\/Side Effects<\/h2>\n<p>Common adverse\/side effects include hypertension, dysrhythmia, dizziness, headache, insomnia, and restlessness. Some clients may experience blurred vision, tinnitus, chest tightness, dry nose, and nasal congestion.<\/p>\n<p>Decongestants are contraindicated in clients with severe hypertension, coronary artery disease (CAD), narrow-angle glaucoma, and some antidepressant use. Also, clients who have cardiac dysrhythmias, hyperthyroidism, DM (diabetes mellitus), prostatic hypertrophy, and glaucoma should use with caution.<a class=\"footnote\" title=\"Frandsen, G. &amp; Pennington, S. (2018). Abrams\u2019 clinical drug: Rationales for nursing practice (11th ed.). Wolters Kluwer.\" id=\"return-footnote-234-2\" href=\"#footnote-234-2\" aria-label=\"Footnote 2\"><sup class=\"footnote\">[2]<\/sup><\/a><\/p>\n<h2>Client Teaching &amp; Education<\/h2>\n<p>Client must take care to follow dosing recommendations.\u00a0 If dosing standards are surpassed, some clients may experience side effects such as increased nervousness, breathing difficulties, heart rate changes, and hallucinations.<a class=\"footnote\" title=\"uCentral from Unbound Medicine. https:\/\/www.unboundmedicine.com\/ucentral\" id=\"return-footnote-234-3\" href=\"#footnote-234-3\" aria-label=\"Footnote 3\"><sup class=\"footnote\">[3]<\/sup><\/a><\/p>\n<h1>Pseudoephedrine Medication Card<\/h1>\n<p>Now let&#8217;s take a closer look at the medication drug card on Pseudoephedrine. Medication cards are intended to assist students to learn key points about each medication class.\u00a0 Basic information related to a common generic medication in this class is outlined, including administration considerations, therapeutic effects, and side effects\/adverse effects.\u00a0 Prototype\/generic medication listed in the medication card is also hyperlinked to a free resource from <a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/index.cfm\" rel=\"noopener noreferrer\">Daily Med<\/a>.\u00a0 Because information about medication is constantly changing, nurses should always consult evidence-based resources to review current recommendations before administering specific medication.in Table 5.7.<span style=\"text-align: initial; font-size: 1em;\"><a class=\"footnote\" title=\"This work is a derivative of\u00a0Pharmacology Notes: Nursing Implications for Clinical Practice\u00a0by\u00a0Gloria Velarde\u00a0is licensed under\u00a0CC BY-NC-SA 4.0.\" id=\"return-footnote-234-4\" href=\"#footnote-234-4\" aria-label=\"Footnote 4\"><sup class=\"footnote\">[4]<\/sup><\/a>, <a class=\"footnote\" title=\"Frandsen, G. &amp; Pennington, S. (2018).\u00a0Abrams\u2019 clinical drug: Rationales for nursing practice\u00a0(11th ed.). Wolters Kluwer.\" id=\"return-footnote-234-5\" href=\"#footnote-234-5\" aria-label=\"Footnote 5\"><sup class=\"footnote\">[5]<\/sup><\/a>, <a class=\"footnote\" title=\"This work is a derivative of\u00a0Daily Med\u00a0by\u00a0U.S. National Library of Medicine\u00a0in the public domain.\" id=\"return-footnote-234-6\" href=\"#footnote-234-6\" aria-label=\"Footnote 6\"><sup class=\"footnote\">[6]<\/sup><\/a>.<br \/>\n<\/span><\/span><\/p>\n<div class=\"textbox textbox--learning-objectives\">\n<header class=\"textbox__header\">\n<h2 class=\"textbox__title\">Medication Card 5.7.1: Pseudoephedrine<\/h2>\n<\/header>\n<div class=\"textbox__content\">\n<p><strong>Class:<\/strong> Decongestants<\/p>\n<p><strong>Prototypes:<\/strong> Pseudoephedrine (Sudafed)<\/p>\n<p><strong>Mechanism: <\/strong>Sudafed is an over the counter decongestant. It acts on the adrenergic receptors by releasing norepinephrine from its storage sites.\u00a0 This causes vasoconstriction-shrinking nasal mucosa membranes.<\/p>\n<h3>Therapeutic Effects<\/h3>\n<ul>\n<li>Relieves nasal congestion<\/li>\n<li>Relieves sinus congestion<\/li>\n<li>Decreases sinus pressure and decrease pain<\/li>\n<\/ul>\n<h3>Administration<\/h3>\n<ul>\n<li>Do not crush, chew, or break an extended release tablet<\/li>\n<li>Oral suspension is available, ensure proper measuring and dose<\/li>\n<li>Adult Doses: Immediate release: 30 to 60 mg orally every 4 to 6 hours as needed.<br \/>\nSustained release: 120 mg orally every 12 hours as needed.<br \/>\nSustained release suspension: 45 to 100 mg orally every 12 hours as needed.<br \/>\nMaximum daily dose is 240 mg\/day.<\/li>\n<\/ul>\n<h3>Indications<\/h3>\n<ul>\n<li>Use of nasal congestion due to common cold and hay fever<\/li>\n<li>Upper respiratory allergies<\/li>\n<li>Temporarily relieves sinus congestions and pressure<\/li>\n<\/ul>\n<h3>Contraindications<\/h3>\n<ul>\n<li>Avoid using prolonged- greater than 7 days<\/li>\n<li>Only use this medication if advised by prescribing practitioner or pharmacist if the person has heart disease since is acts as a sympathomimetic<\/li>\n<li>This drug is banned for professional sports by the World Anti-Doping Agency as it is a stimulant and is claimed to enhance performance<\/li>\n<li>DO not use in children under 4 years of age<\/li>\n<li>DO not take if taking MAO inhibitors within 14 days, this leads to serious side effects.<\/li>\n<li>DO not take if\u00a0 taking caffeine pills, diet pills or other stimulants such as ADHA medications<\/li>\n<\/ul>\n<h3>Side Effects<\/h3>\n<ul>\n<li>Rebound congestion with nasal route<\/li>\n<li>Cardiovascular stimulation-fast heartbeat or pounding heart beat sensation<\/li>\n<li>Dizziness or anxiety<\/li>\n<li>Dangerously high blood pressure<\/li>\n<li>Loss of appetite<\/li>\n<li>Fever, headache, cough, or skin rash-contact doctor<\/li>\n<\/ul>\n<p><strong>SAFETY:<\/strong> \u00a0Cautious when administering to cardiac patients due to the stimulation it can cause<\/p>\n<ul>\n<li>Death can occur in misuse of cough and cold drugs in very young children<\/li>\n<li>Many over the counter drugs have combination of cough and cold drugs mixed together read the label to ensure you are not taking more drugs than indicated<\/li>\n<li>Can cross into breast milk and could harm a nursing baby<\/li>\n<\/ul>\n<h3>Nursing Considerations<\/h3>\n<ul>\n<li>Drink at least 2-3 litres of water per day<\/li>\n<li>Ensure prescribing doctor thinks its ok to take this medication if the person has heart disease, diabetes or a thyroid disorder<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<hr class=\"before-footnotes clear\" \/><div class=\"footnotes\"><ol><li id=\"footnote-234-1\">\"<a href=\"https:\/\/www.flickr.com\/photos\/comedynose\/7184518521\" rel=\"noopener noreferrer\">Project 366 #165: 130612 Helping Hand?<\/a>\" by <a href=\"https:\/\/www.flickr.com\/photos\/comedynose\/\" rel=\"noopener noreferrer\">Pete<\/a> is licensed under <a href=\"https:\/\/creativecommons.org\/publicdomain\/mark\/1.0\/\" rel=\"noopener noreferrer\">public domain<\/a> <a href=\"#return-footnote-234-1\" class=\"return-footnote\" aria-label=\"Return to footnote 1\">&crarr;<\/a><\/li><li id=\"footnote-234-2\">Frandsen, G. &amp; Pennington, S. (2018). <em>Abrams\u2019 clinical drug: Rationales for nursing practice <\/em>(11th ed.). Wolters Kluwer. <a href=\"#return-footnote-234-2\" class=\"return-footnote\" aria-label=\"Return to footnote 2\">&crarr;<\/a><\/li><li id=\"footnote-234-3\">uCentral from Unbound Medicine. <a href=\"https:\/\/www.unboundmedicine.com\/ucentral\" rel=\"noopener noreferrer\">https:\/\/www.unboundmedicine.com\/ucentral<\/a> <a href=\"#return-footnote-234-3\" class=\"return-footnote\" aria-label=\"Return to footnote 3\">&crarr;<\/a><\/li><li id=\"footnote-234-4\">This work is a derivative of\u00a0<a href=\"https:\/\/www.oercommons.org\/authoring\/54330-pharmacology-notes-nursing-implications-for-clinic\/view\" rel=\"noopener noreferrer\">Pharmacology Notes: Nursing Implications for Clinical Practice<\/a>\u00a0by\u00a0<a href=\"https:\/\/www.oercommons.org\/profile\/213497\" rel=\"noopener noreferrer\">Gloria Velarde<\/a>\u00a0is licensed under\u00a0<a class=\"internal\" href=\"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/\" rel=\"noopener noreferrer\">CC BY-NC-SA 4.0<\/a>. <a href=\"#return-footnote-234-4\" class=\"return-footnote\" aria-label=\"Return to footnote 4\">&crarr;<\/a><\/li><li id=\"footnote-234-5\">Frandsen, G. &amp; Pennington, S. (2018).\u00a0<em>Abrams\u2019 clinical drug: Rationales for nursing practice\u00a0<\/em>(11th ed.). Wolters Kluwer. <a href=\"#return-footnote-234-5\" class=\"return-footnote\" aria-label=\"Return to footnote 5\">&crarr;<\/a><\/li><li id=\"footnote-234-6\">This work is a derivative of\u00a0<a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/\" rel=\"noopener noreferrer\">Daily Med<\/a>\u00a0by\u00a0<a href=\"https:\/\/www.nlm.nih.gov\/\" rel=\"noopener noreferrer\">U.S. National Library of Medicine<\/a><span style=\"font-size: 1em;\">\u00a0in the <a class=\"internal\" href=\"https:\/\/creativecommons.org\/share-your-work\/public-domain\/\" rel=\"noopener noreferrer\">public domain<\/a>.  <a href=\"#return-footnote-234-6\" class=\"return-footnote\" aria-label=\"Return to footnote 6\">&crarr;<\/a><\/li><\/ol><\/div>","protected":false},"author":90,"menu_order":7,"template":"","meta":{"pb_show_title":"on","pb_short_title":"","pb_subtitle":"","pb_authors":[],"pb_section_license":""},"chapter-type":[50],"contributor":[],"license":[],"class_list":["post-234","chapter","type-chapter","status-publish","hentry","chapter-type-numberless"],"part":209,"_links":{"self":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/234","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters"}],"about":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/wp\/v2\/types\/chapter"}],"author":[{"embeddable":true,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/wp\/v2\/users\/90"}],"version-history":[{"count":5,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/234\/revisions"}],"predecessor-version":[{"id":1731,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/234\/revisions\/1731"}],"part":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/parts\/209"}],"metadata":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/234\/metadata\/"}],"wp:attachment":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/wp\/v2\/media?parent=234"}],"wp:term":[{"taxonomy":"chapter-type","embeddable":true,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapter-type?post=234"},{"taxonomy":"contributor","embeddable":true,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/wp\/v2\/contributor?post=234"},{"taxonomy":"license","embeddable":true,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/wp\/v2\/license?post=234"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}